United States Fabry Disease Treatment Research Report 2024: Market Size, Trends, Competition, Forecasts and Opportunities, 2019-2029
27 août 2024 10h09 HE
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "United States Fabry Disease Treatment Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
Protalix BioTherapeutics Announces Additional Positive Data from its Phase I/II Clinical Trial for PRX-102 for the Treatment of Fabry Disease
10 août 2016 07h30 HE
|
Protalix BioTherapeutics, Inc.
CARMIEL, Israel, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today additional positive data from its phase I/II clinical trial of...